PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 54 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $63,000 | -6.0% | 101,617 | 0.0% | 0.00% | – |
Q1 2017 | $67,000 | +116.1% | 101,617 | 0.0% | 0.00% | – |
Q4 2016 | $31,000 | -27.9% | 101,617 | -0.0% | 0.00% | – |
Q3 2016 | $43,000 | +16.2% | 101,619 | 0.0% | 0.00% | – |
Q2 2016 | $37,000 | -96.5% | 101,619 | -96.0% | 0.00% | – |
Q1 2016 | $1,070,000 | -62.5% | 2,546,696 | +4.4% | 0.00% | – |
Q4 2015 | $2,854,000 | +17.5% | 2,440,069 | +2.5% | 0.00% | – |
Q3 2015 | $2,429,000 | -23.5% | 2,381,043 | -1.7% | 0.00% | – |
Q2 2015 | $3,176,000 | +4.6% | 2,423,438 | +7.8% | 0.00% | – |
Q1 2015 | $3,036,000 | -2.2% | 2,248,886 | +0.6% | 0.00% | – |
Q4 2014 | $3,105,000 | +5.1% | 2,234,885 | +2.8% | 0.00% | – |
Q3 2014 | $2,954,000 | -27.0% | 2,173,530 | +1.0% | 0.00% | – |
Q2 2014 | $4,046,000 | -1.1% | 2,152,610 | -0.1% | 0.00% | – |
Q1 2014 | $4,092,000 | +59.1% | 2,153,838 | +16.2% | 0.00% | – |
Q4 2013 | $2,572,000 | +16.4% | 1,854,205 | +18.5% | 0.00% | – |
Q3 2013 | $2,209,000 | +26.7% | 1,565,150 | +15.6% | 0.00% | – |
Q2 2013 | $1,744,000 | – | 1,353,519 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delaney Dennis R | 60,000 | $25,000 | 0.05% |
Freedom Investment Management, Inc. | 1,422,314 | $597,000 | 0.04% |
Sterling Global Strategies LLC | 10,000 | $4,000 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,009,400 | $424,000 | 0.01% |
CORRADO ADVISORS, LLC | 15,000 | $6,000 | 0.00% |
First Heartland Consultants, Inc. | 17,240 | $7,000 | 0.00% |
Tower Research Capital LLC (TRC) | 37,955 | $16,000 | 0.00% |
Commonwealth Equity Services, Inc | 486,961 | $205,000 | 0.00% |
QS Investors, LLC | 503,400 | $212,000 | 0.00% |
Perceptive Advisors | 24,332 | $10,000 | 0.00% |